Here's the latest coronavirus-related news.
The number of coronavirus disease 2019 (COVID-19) cases in the United States continue to surge, with a weekly average of 222,000 daily cases and an estimated 129,000 COVID-19––related hospitalizations as of January 14, according to The COVID Tracking Project.
Here’s a roundup of the latest coronavirus-related news:
Remdesivir in the Treatment of COVID-19
An overview of the use of remdesivir for the treatment of COVID-19. On October 22, 2020, the FDA approved remdesivir (Veklury; Gilead) as the first treatment for COVID-19. Remdesivir is now indicated for adult or pediatric patients 12 years of age and older weighing at least 40 kilograms for the treatment of COVID-19 requiring hospitalization.
The Pharmacist’s Role Beyond COVID-19
Over the years, pharmacists have worked hard to establish themselves as core members of a patient’s care team and today, amid the pandemic, how effectively they embrace their role as frontline care providers could change the profession forever.
Operation Warp Speed Announces Changes to COVID-19 Vaccine Distribution Strategy
In a briefing on Tuesday, Operation Warp Speed officials announced several milestones and updates in its campaign for delivering COVID-19 vaccines to the United States.
FDA Reviewing Effects of COVID-19 Variants on Diagnostic Tests
FDA officials have released an alert for clinical laboratory staff and health care providers regarding information on viral mutations of COVID-19.
How Does Digital Data Help Improve QOL in Patients With Long COVID and Autoimmune Diseases?
May 30th 2023Quality of life (QOL) for people living with autoimmune diseases benefits from an integrated approach that considers individual immune system sensitivities and patients’ life circumstances, a new study shows.
2 Clarke Drive
Cranbury, NJ 08512